Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Relative Valuation - Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 29.87 CNY -1.58% Market Closed

Market Cap: ¥9.4B

J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	CN

Multiples-Based Value

The Multiples-Based Value of one Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd stock under the Base Case scenario is 44.65 CNY. Compared to the current market price of 29.87 CNY, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd is Undervalued by 33%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is relative valuation?

How is Multiples-Based Value calculated?

Multiples-Based Value

Base Case

Undervaluation 33%

Multiples-Based Value

Price ¥29.87

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	9.4B CNY	5	18.9	18.5	18.5
US		Eli Lilly and Co NYSE:LLY	883.9B USD	13.6	42.8	28.9	30.8
US		Johnson & Johnson NYSE:JNJ	585.2B USD	6.2	21.8	15.2	18.6
UK		AstraZeneca PLC LSE:AZN	237.5B GBP	5.4	31.2	17.2	24.2
CH		Roche Holding AG SIX:ROG	248.4B CHF	4.1	19.7	11.6	13.1
US		Merck & Co Inc NYSE:MRK	299.1B USD	4.6	16.4	10.1	12.3
CH		Novartis AG SIX:NOVN	236.4B CHF	5.4	21.8	13.5	17.3
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.4	10.3	7.6	9
US		Pfizer Inc NYSE:PFE	161B USD	2.6	20.7	7.9	10.5
US		Bristol-Myers Squibb Co NYSE:BMY	120B USD	2.5	17	7.2	8.8

				Revenue Growth	P/S to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average P/S: 14.1 5	35%	0.1
US		Eli Lilly and Co NYSE:LLY	13.6	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	7%	0.9
UK		AstraZeneca PLC LSE:AZN	5.4	N/A	N/A
CH		Roche Holding AG SIX:ROG	4.1	4%	1
US		Merck & Co Inc NYSE:MRK	4.6	5%	0.9
CH		Novartis AG SIX:NOVN	5.4	5%	1.1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	1%	3.4
US		Pfizer Inc NYSE:PFE	2.6	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average P/E: 22.1 18.9	37%	0.5
US		Eli Lilly and Co NYSE:LLY	42.8	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.8	7%	3.1
UK		AstraZeneca PLC LSE:AZN	31.2	26%	1.2
CH		Roche Holding AG SIX:ROG	19.7	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.4	14%	1.2
CH		Novartis AG SIX:NOVN	21.8	14%	1.6
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.3	1%	10.3
US		Pfizer Inc NYSE:PFE	20.7	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	17	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average EV/EBITDA: 46.6 18.5	47%	0.4
US		Eli Lilly and Co NYSE:LLY	28.9	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15.2	2%	7.6
UK		AstraZeneca PLC LSE:AZN	17.2	13%	1.3
CH		Roche Holding AG SIX:ROG	11.6	6%	1.9
US		Merck & Co Inc NYSE:MRK	10.1	3%	3.4
CH		Novartis AG SIX:NOVN	13.5	5%	2.7
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.6	1%	7.6
US		Pfizer Inc NYSE:PFE	7.9	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.2	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
CN	J	Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076	Average EV/EBIT: 100.4 18.5	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	30.8	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.6	6%	3.1
UK		AstraZeneca PLC LSE:AZN	24.2	21%	1.2
CH		Roche Holding AG SIX:ROG	13.1	6%	2.2
US		Merck & Co Inc NYSE:MRK	12.3	6%	2.1
CH		Novartis AG SIX:NOVN	17.3	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9	2%	4.5
US		Pfizer Inc NYSE:PFE	10.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.8	-7%	N/A

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd SSE:688076

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Competitors Multiples
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd Competitors